本文選題：人脂聯(lián)素 + 糖尿病��； 參考：《天津醫(yī)科大學(xué)》2008年碩士論文

【摘要】：目的：在人肝細(xì)胞株L-02中獲取具有生物學(xué)活性的脂聯(lián)素重組蛋白的分泌性表達(dá),并在L-02細(xì)胞中探討脂聯(lián)素抑制糖異生的信號(hào)轉(zhuǎn)導(dǎo)機(jī)制。 方法：①?gòu)娜酥窘M織中提取總RNA,利用RT-PCR方法得到人脂聯(lián)素基因cDNA序列,自行設(shè)計(jì)引物一對(duì),經(jīng)PCR擴(kuò)增人脂聯(lián)素基因完全編碼序列,構(gòu)建pMD18-T/ADPN重組克隆質(zhì)粒,目的序列測(cè)序鑒定；PCR擴(kuò)增脂聯(lián)素目的片段,連至真核表達(dá)載體pCDNA3.1/CT-GFP-TOPO,構(gòu)建脂聯(lián)素真核表達(dá)質(zhì)粒pCDNA3.1/CT-GFP-TOPO-ADPN。②將pCDNA3.1/CT-GFP-TOPO-ADPN轉(zhuǎn)化入TOP10感受態(tài)細(xì)胞,篩選可能含有陽(yáng)性克隆的白色菌落進(jìn)行鑒定,提取陽(yáng)性克隆中的重組質(zhì)粒,命名為pCDNA3.1-ADPN。③將pCDNA3.1—ADPN經(jīng)脂質(zhì)體介導(dǎo)、G418篩選后轉(zhuǎn)染至人肝細(xì)胞株L-02,免疫熒光法觀察轉(zhuǎn)染率,收獲的細(xì)胞裂解液及細(xì)胞培養(yǎng)上清經(jīng)SDS-PAGE、western blot、細(xì)胞免疫組織化學(xué)法檢測(cè)脂聯(lián)素表達(dá)情況。④用含0 mmol/L、5 mmol/L、15 mmol/L和30 mmol/L葡萄糖的培基分別模擬無糖、低糖、中糖、高糖環(huán)境。將轉(zhuǎn)染pCDNA3.1—ADPN的L-02細(xì)胞和對(duì)照組分別在上述環(huán)境中處理24 h,酶學(xué)法測(cè)定培養(yǎng)基血糖,觀察重組脂聯(lián)素蛋白的活性。⑤以western blot測(cè)定正常L-02組、轉(zhuǎn)染組、30 mmol/L glucose處理組和“饑餓”組(72 h未換液)中phospho-AMPK、及其下游環(huán)腺苷酸反應(yīng)元件結(jié)合蛋白(CREB)、phospho-CREB蛋白表達(dá)情況,免疫組化法觀察四組細(xì)胞中環(huán)腺苷酸反應(yīng)元件結(jié)合蛋白輔激活物2(TORC2)的定位情況,葡萄糖脫氫酶偶聯(lián)法測(cè)定葡萄糖-6-磷酸酶(G6P)活性。 結(jié)果：①成功構(gòu)建脂聯(lián)素克隆質(zhì)粒pMD18-T/ADPN和真核表達(dá)質(zhì)粒pCDNA3.1/CT-GFP-TOPO-ADPN(簡(jiǎn)稱pCDNA3.1-ADPN)。②轉(zhuǎn)染pCDNA3.1-ADPN的L-02細(xì)胞在免疫熒光顯微鏡下可見綠色熒光,表明轉(zhuǎn)染成功,轉(zhuǎn)染率在60%以上。③在細(xì)胞培養(yǎng)上清和沉淀中均檢測(cè)到表達(dá)產(chǎn)物,表明重組蛋白利用自身信號(hào)肽獲得分泌性表達(dá)。細(xì)胞裂解液和細(xì)胞培養(yǎng)上清中表達(dá)的重組蛋白分子量約為57 kD,具有人脂聯(lián)素抗原性。④轉(zhuǎn)染pCDNA3.1—ADPN的L-02細(xì)胞高糖(30mmol/L)處理24 h后其培基血糖低于對(duì)照組(p0.05),但在無糖、低糖和中糖環(huán)境中無明顯差異(p0.05)。⑤與其它組比較,轉(zhuǎn)染組：phospho-AMPK蛋白表達(dá)升高(p0.05), TORC2主要在定位在細(xì)胞質(zhì)中,G6P酶的活性顯著降低(p0.05),但CREB、phospho-CREB蛋白表達(dá)無明顯差異(p0.05)。 結(jié)論：我們成功構(gòu)建了人脂聯(lián)素真核表達(dá)質(zhì)粒,并在人肝細(xì)胞株L-02中得到可溶性、分泌性表達(dá),獲得的重組蛋白具有生物學(xué)活性。脂聯(lián)素抑制糖異生的機(jī)制可能與活化phospho-AMPK,抑制TORC2進(jìn)入核內(nèi),從而抑制糖異生酶G6P的表達(dá)有關(guān),其信號(hào)轉(zhuǎn)導(dǎo)通路可能為Adiponectin-AMPK-CREB-TORC2-糖異生關(guān)鍵酶。這為進(jìn)一步研究脂聯(lián)素的信號(hào)通路,并探尋新的信號(hào)分子奠定了堅(jiān)實(shí)的基礎(chǔ)。
[Abstract]:Aim: to obtain the secretory expression of adiponectin recombinant protein with biological activity in L-02 cell line and to explore the signal transduction mechanism of adiponectin in L-02 cells.Methods the cDNA sequence of human adiponectin gene was obtained from human adipose tissue by RT-PCR. A pair of primers were designed and amplified by PCR to construct the recombinant plasmid of pMD18-T/ADPN.Objective to sequence and amplify the adiponectin target fragment by PCR, and connect it to the eukaryotic expression vector pCDNA3.1 / CT-GFP-TOPO. construct the adiponectin eukaryotic expression plasmid pCDNA3.1/CT-GFP-TOPO-ADPN.2 to transform pCDNA3.1/CT-GFP-TOPO-ADPN into TOP10 receptive cells and screen the white colony which may contain positive clones for identification.The recombinant plasmid was extracted from the positive clone and named as pCDNA3.1-ADPN.3. The pCDNA3.1-ADPN was screened by liposome and transfected into human hepatocyte strain L-02. The transfection rate was observed by immunofluorescence.The expression of adiponectin in the cell lysate and cell culture supernatant was detected by SDS-PAGEG western blot.4 the glucose free, low, medium and high glucose environments were simulated by a culture containing 0 mmol / L 5 mmol 路L ~ (-1) L ~ (15) mmol/L and 30 mmol/L glucose, respectively.The L-02 cells transfected with pCDNA3.1-ADPN and the control group were treated in the above environment for 24 hours respectively. The blood glucose of the culture medium was measured by enzymatic method. The activity of recombinant adiponectin protein was observed. The activity of recombinant adiponectin protein was measured by western blot in normal L-02 group.Phospho-AMPK and its downstream cyclic adenylate response element binding protein (CREBEB-CREB) were expressed in 30 mmol/L glucose treatment group and "hunger" group for 72 h.The localization of cyclic adenylate response element binding protein coactivator (TORC2) was observed by immunohistochemical method. The activity of glucose-6-phosphatase (G6P) was determined by glucose dehydrogenase coupling method.Results pMD18-T/ADPN and eukaryotic expression plasmid pCDNA3.1 / CT-GFP-TOPO-ADPN (pCDNA3.1-ADPN).2 transfected L-02 cell line) were successfully constructed by using 1: 1 adiponectin clone plasmid. Green fluorescence was observed in L-02 cells transfected with pCDNA3.1-ADPN under immunofluorescence microscope, indicating that the transfection was successful.The expression products were detected in the supernatant and precipitate of cell culture with transfection efficiency of more than 60%, indicating that the recombinant protein was secreted by using its own signal peptide.The molecular weight of the recombinant protein expressed in the cell lysate and cell culture supernatant was about 57 kD.The L-02 cell line with human adiponectin antigenicity was treated with high glucose 30 mmol / L for 24 h.There was no significant difference between low and medium sugar environment. Compared with other groups, the expression of TORC2 protein in the transfected group was higher than that in the other groups. The activity of G6P enzyme was significantly decreased in the cytoplasm of the transfected group, but there was no significant difference in the expression of phospho-CREB protein in the cytoplasm of the transfected group.Conclusion: we successfully constructed the eukaryotic expression plasmid of human adiponectin and obtained soluble and secretory expression in L-02 cell line. The recombinant protein has biological activity.The mechanism of adiponectin inhibiting glycosylation may be related to the activation of phospho-AMPK and the inhibition of TORC2 into the nucleus, thus inhibiting the expression of G6P. The signal transduction pathway of adiponectin-AMPK-CREB-TORC2-glycosylated key enzyme may be related to adiponectin-AMPK-CREB-TORC2-glycosylation.This provides a solid basis for the further study of adiponectin signaling pathway and the exploration of new signaling molecules.
【學(xué)位授予單位】：天津醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2008
【分類號(hào)】：R363

【參考文獻(xiàn)】

相關(guān)期刊論文 前9條

1 鄭光宇;真核生物表達(dá)系統(tǒng)研究進(jìn)展[J];喀什師范學(xué)院學(xué)報(bào);2004年06期

2 崔進(jìn)梅,宋磊,鄧學(xué)箴,潘顯玲;基因工程藥物的表達(dá)系統(tǒng)及發(fā)展?fàn)顩r[J];齊魯藥事;2005年02期

3 胡小波,張育堅(jiān),張惠堂,楊勝利,龔毅;脂肪組織特異表達(dá)的脂連蛋白(Adiponectin)及其球狀區(qū)的克隆表達(dá)及體內(nèi)活性的檢測(cè)(英文)[J];生物化學(xué)與生物物理學(xué)報(bào);2003年11期

4 劉宏磊;李希;宋后燕;湯其群;;人脂聯(lián)素球狀結(jié)構(gòu)域的表達(dá)、純化和功能鑒定[J];復(fù)旦學(xué)報(bào)(醫(yī)學(xué)版);2006年01期

5 劉定燮,周曉巍,黃培堂;哺乳動(dòng)物細(xì)胞表達(dá)系統(tǒng)及其研究進(jìn)展[J];生物技術(shù)通訊;2003年04期

6 劉德敏;楊莉麗;孫穎;張捷;;人脂聯(lián)素基因的克隆及在大腸桿菌中的表達(dá)[J];天津醫(yī)藥;2006年03期

7 劉德敏;杜春紅;孫穎;張捷;;綠色熒光蛋白標(biāo)記的人脂聯(lián)素真核表達(dá)載體的構(gòu)建[J];天津醫(yī)藥;2007年05期

8 杜春紅;劉德敏;;人脂聯(lián)素基因在L-02細(xì)胞中表達(dá)及其功能檢測(cè)[J];天津醫(yī)藥;2008年04期

9 李丙蓉;鄧華聰;蘭麗珍;鄭宏庭;劉金波;;人脂聯(lián)素基因真核表達(dá)載體的構(gòu)建及在HEK293細(xì)胞中的表達(dá)[J];中華內(nèi)分泌代謝雜志;2006年05期

相關(guān)碩士學(xué)位論文 前1條

1 靳立忠;脂聯(lián)素基因的克隆及其多態(tài)性研究[D];天津醫(yī)科大學(xué);2004年

，

本文編號(hào)：1754458